Nuvo Pharmaceuticals Inc
F:23N
Nuvo Pharmaceuticals Inc
F:23N
Price:
0.9
EUR
-1.64%
Market Closed
Market Cap:
€10.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Nuvo Pharmaceuticals Inc
F:23N
|
CA |
|
Washington H Soul Pattinson and Company Ltd
F:WD3
|
AU |
|
M
|
Macy's Inc
XMUN:FDO
|
US |
|
Gestamp Automocion SA
F:7GA
|
ES |
|
C
|
Columbia Sportswear Co
F:CUW
|
US |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
XMUN:AIL
|
FR |
|
V
|
Vinci SA
F:SQUA
|
FR |
|
R
|
Ramelius Resources Ltd
XBER:RRZ
|
AU |
|
I
|
Interpublic Group of Companies Inc
F:IPG
|
US |
|
F
|
Fluor Corp
DUS:FLU
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 23N's stock price target?
Not Available
23N does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Nuvo Pharmaceuticals Inc?
Projected CAGR
5%
5%
Over the last 8 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 2 years is 5%.
What is the Operating Income forecast for Nuvo Pharmaceuticals Inc?
Projected CAGR
-26%
-26%
The compound annual growth rate for Operating Income over the next 4 years is -26%.
